Science & Research
Backed by Clinical Evidence
FenuFiber’s health claims are substantiated by peer-reviewed clinical trials and advanced in-vitro studies conducted at leading research institutions worldwide.
How It Works
Mechanism of Action
FenuFiber’s unique blend of soluble and insoluble galactomannan fiber works through multiple physiological pathways.
Viscosity Formation
FenuFiber's soluble galactomannan fiber creates a viscous gel in the small intestine, increasing the thickness of the food bolus.
Enzyme Interaction Delay
The viscous gel slows the interaction between digestive enzymes and nutrients, reducing the rate at which glucose is released and absorbed.
GLP-1 Stimulation
Delayed nutrient breakdown delivers food to the distal ileum, stimulating L-cells to release GLP-1 (glucagon-like peptide-1), a key hormone for insulin regulation.
Microbiome Nourishment
Undigested fiber reaches the colon where it is fermented by beneficial bacteria, producing SCFAs that support gut barrier integrity and immune function.
Clinical Studies
Published Research
Glycemic Control in Type 2 Diabetes
Madras Diabetes Research Foundation
Double-blind, placebo-controlled human clinical trial • Subjects with Type 2 diabetes
This landmark study demonstrated that FenuFiber's unique galactomannan fiber matrix significantly improved blood sugar markers in diabetic subjects, establishing a strong foundation for its use in diabetic nutrition products.
Key Findings:
- Significant reduction in fasting blood glucose levels
- Measurable decrease in HbA1c (glycated hemoglobin)
- Improved glycemic variability over the study period
- No adverse side effects reported
Glycemic Index Reduction in Healthy Adults
Madras Diabetes Research Foundation
Randomized human clinical trial • Healthy adult volunteers
This study proved that incorporating FenuFiber into common foods can lower their glycemic impact, making it a valuable tool for food manufacturers developing better-for-you products.
Key Findings:
- Reduced Glycemic Index of high-GI foods when co-consumed
- Attenuated post-meal blood glucose spikes
- Demonstrated dose-response relationship
- Applicable to food fortification strategies
Prebiotic Effects & Gut Microbiome
ProDigest, Belgium
In-vitro colonic simulation (SHIME® model) • Simulated human intestinal microbial ecosystem
Using an advanced colonic simulation model, this study revealed FenuFiber's powerful prebiotic properties — supporting beneficial gut bacteria while producing fewer uncomfortable side effects than other fibers.
Key Findings:
- Stimulated production of short-chain fatty acids (SCFAs)
- Increased acetate, propionate, and butyrate levels
- Reduced gas production compared to other fiber sources
- Less bloating potential than conventional fibers
Health Benefits
Comprehensive Wellness Support
Cardiovascular Health
Supports healthy cholesterol levels through bile acid binding and reduced lipid absorption.
Blood Sugar Balance
Clinically proven to reduce fasting glucose, HbA1c, and post-meal glucose spikes.
Gut-Brain Axis
Prebiotic SCFAs support gut-brain communication and may improve mood and cognition.
Satiety & Weight
Viscous fiber gel increases feelings of fullness, reducing overall caloric intake.
Digestive Comfort
Unlike other fibers, FenuFiber causes less gas, bloating, and gastrointestinal discomfort.
Nutrient Absorption
Supports mineral absorption and does not interfere with uptake of essential micronutrients.
Want to Review the Full Research?
Our science team can provide detailed clinical study reports, white papers, and technical documentation.